DGDanielle Gulick

Danielle Gulick

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Danielle Gulick has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cannabidiol enhances the ability of delta-9-tetrahydrocannabinol to reduce alcohol intake in the Syrian golden hamster

    by Daniel Moreira-Silva, Yejoon Sohn, Alan Green, Joshua Gamsby, Danielle Gulick

    Delta-9-tetrahydrocannabinol (THC, a CB1 partial agonist) and cannabidiol (CBD, a CB1 inverse agonist) have high therapeutic value. We examined whether THC or CBD, alone or in combination, alters voluntary alcohol intake in Syrian golden hamsters. Adult male hamsters (15% v/v alcohol vs. water) were pseudorandomized across four 14–16-day regimens: Exp 1 assessed static THC (1–20 mg/kg) or CBD (5–40 mg/kg) with a 7-day withdrawal phase; Exp 2 evaluated escalating THC (1–40 mg/kg) with constant CBD (5–40 mg/kg); Exp 3 tested escalating low-dose THC (0.1–2 mg/kg) ± CBD (60 mg/kg); and Exp 4 tested moderate-dose THC (1, 2, or 5 mg/kg) ± CBD (60 mg/kg). Chronic THC decreased alcohol intake and preference; at low doses, this effect was significantly enhanced and sustained across late withdrawal by high-dose CBD co-administration. CBD alone failed to alter drinking patterns. Metabolically, static high-dose THC administration induced marked weight loss, whereas dynamic mid-dose THC escalation significantly enhanced body weight gain despite steady caloric intake. Although central CB1 activation typically promotes alcohol consumption, chronic THC suppressed voluntary alcohol intake, an effect enhanced by CBD co-administration. Thus, high CBD:THC formulations may represent an effective, translationally relevant strategy for alcohol misuse.

  • Open Access

    Serotonergic Polypharmacology of 2-Halogenated Tryptamines

    by Jeanine Yacoub, Elena Bray, Jude Bayyat, Grant C Glatfelter, Alex Leake, Emilia M Buitrago, Alexander D Maitland, John Partilla, Natalie G Cavalco, Serena S Schalk, et al.

    Serotonergic psychedelics such as N,N-dimethyltryptamine (DMT) and 4-phosphoryloxy-N,N-dimethyltryptamine (psilocybin) show therapeutic promise for psychiatric and neurodegenerative disorders but may be limited by liabilities from serotonin (5-HT)-2A mediated psychoactive effects and potential cardiotoxicity via 5-HT2B activation. To address these limitations, we designed and synthesized 2-halogenated derivatives of DMT and psilacetin to reduce 5-HT2A/5-HT2B activity while retaining engagement of therapeutically relevant targets, particularly 5-HT6, 5-HT2C, and 5-HT1B. This study demonstrated that 2-position halogenation decreased affinities, potencies, and efficacies at 5-HT2A and 5-HT1A receptors while preserving potent 5-HT6 agonism, especially for 2-Br-psilocin. The analogues exhibited reduced affinities at 5-HT2B and hERG ion channels, suggesting safer cardiac valve and cardiotoxic profiles. In C57BL/6J mice, 2-Br-psilacetin did not induce the head-twitch response and attenuated 2,5 dimethoxy-4-iodoamphetamine (DOI)-induced head-twitch behavior, suggesting a reduced potential for inducing psychedelic effects. Behavioral assays further revealed improvements in stress-induced affective measures and hippocampus-independent cued learning at intermediate doses. These findings identify 2-halogenated tryptamines as polypharmacological serotonergic ligands with reduced psychoactivity and cardiac valve and toxic liabilities, supporting their potential as next-generation psychedelic-inspired therapeutics.


  • Open Access

    FKBP51 overexpression in the corticolimbic system stabilizes circadian rhythms

    by Niat T. Gebru, David Beaulieu-Abdelahad, Danielle Gulick, Laura J. Blair


  • How Student and Faculty Perceptions Differ on the Stressors that Medical Students Face

    by Katsiaryna Khatskevich, Jiten Patel, Sierra Klein, Lachlan Shiver, Ashley Mason, Danielle Gulick, Md, Bs, Ba, Ph D

    Objectives: Medical education is notorious for the stress that students face as they strive to succeed both academically and clinically. This stress has been linked to declining academic performance and worsening mental health. To combat these negative outcomes, it is essential for medical school faculty and administration to address common stressors among medical students. No studies have...


  • Matching Against Men: 5 Years of Residency Match Data Show Disparities Still Exist

    by Ashley Mason, Zeegan George, Katsiaryna Khatskevich, Xiaoxiao Gao, Kira Zwygart, Danielle Gulick, Ba, Bs, Md, Ph D

    Objectives: Despite progress toward equal representation by sex in medical practice, women remain underrepresented in many specialties. This study sought to examine the current state of gender equality among recently graduated doctors in multiple specialties. Methods: Deidentified demographics, standardized examination scores, and Match results were gathered for 829 graduates. Participants...


  • Open Access

    DISC1 and reelin interact to alter cognition, inhibition, and neurogenesis in a novel mouse model of schizophrenia

    by Heather L. Mahoney, Charissa A. Bloom, Hannah S. Justin, Bianca M. Capraro, Christopher Morris, David Gonzalez, Emily Sandefur, John Faulkner, Samantha Reiss, Angel Valladares, et al.

    The etiology of schizophrenia (SCZ) is multifactorial, and depending on a host of genetic and environmental factors. Two putative SCZ susceptibility genes, Disrupted-in-Schizophrenia-1 (DISC1) and reelin (RELN), interact at a molecular level, suggesting that combined disruption of both may lead to an intensified SCZ phenotype. To examine this gene–gene interaction, we produced a double mutant mouse line. Mice with heterozygous RELN haploinsufficiency were crossed with mice expressing dominant-negative c-terminal truncated human DISC1 to produce offspring with both mutations (HRM/DISC1 mice). We used an array of behavioral tests to generate a behavioral phenotype for these mice, then examined the prefrontal cortex and hippocampus using western blotting and immunohistochemistry to probe for SCZ-relevant molecular and cellular alterations. Compared to wild-type controls, HRM/DISC1 mice demonstrated impaired pre-pulse inhibition, altered cognition, and decreased activity. Diazepam failed to rescue anxiety-like behaviors, paradoxically increasing activity in HRM/DISC1 mice. At a cellular level, we found increased α1-subunit containing GABA receptors in the prefrontal cortex, and a reduction in fast-spiking parvalbumin positive neurons. Maturation of adult-born neurons in the hippocampus was also altered in HRM/DISC1 mice. While there was no difference in the total number proliferating cells, more of these cells were in immature stages of development. Homozygous DISC1 mutation combined with RELN haploinsufficiency produces a complex phenotype with neuropsychiatric characteristics relevant to SCZ and related disorders, expanding our understanding of how multiple genetic susceptibility factors might interact to influence the variable presentation of these disorders.


  • Student-Produced Guides alongside First-Year Medical Curriculum: How Peer-Produced Textbooks Change Student Success within Neurology, Cardiopulmonary, and Mixed Systems Courses

    by Ashley Mason, Zeegan George, Danielle Gulick, Ba, Bs, Ph D

    Objectives: In the United States, medical schools do not have a unified curricular plan that integrates basic sciences and organ-based systems in undergraduate medical education. Instead, institutions rely on independently created lecture material during the first-year medical school curriculum. The drawback to this approach is that no commercial or organizational resources cater to this...


  • Circadian rhythm shifts and alcohol access in adolescence synergistically increase alcohol preference and intake in adulthood in male C57BL/6 mice

    by David Gonzalez, Hannah Justin, Samantha Reiss, John Faulkner, Heather Mahoney, Amara Yunus, Joshua Gamsby, Danielle Gulick


  • Open Access

    Impact of Alcohol Abuse on Susceptibility to Rare Neurodegenerative Diseases

    by Iskra Araujo, Amy Henriksen, Joshua Gamsby, Danielle Gulick

    Despite the prevalence and well-recognized adverse effects of prenatal alcohol exposure and alcohol use disorder in the causation of numerous diseases, their potential roles in the etiology of neurodegenerative diseases remain poorly characterized. This is especially true of the rare neurodegenerative diseases, for which small population sizes make it difficult to conduct broad studies of specific etiological factors. Nonetheless, alcohol has potent and long-lasting effects on neurodegenerative substrates, at both the cellular and systems levels. This review highlights the general effects of alcohol in the brain that contribute to neurodegeneration across diseases, and then focuses on specific diseases in which alcohol exposure is likely to play a major role. These specific diseases include dementias (alcohol-induced, frontotemporal, and Korsakoff syndrome), ataxias (cerebellar and frontal), and Niemann-Pick disease (primarily a Type B variant and Type C). We conclude that there is ample evidence to support a role of alcohol abuse in the etiology of these diseases, but more work is needed to identify the primary mechanisms of alcohol’s effects.


  • Open Access

    Inhibition of casein kinase 1 δ/ε improves cognitive performance in adult C57BL/6J mice

    by Heather Mahoney, Emily Peterson, Hannah Justin, David Gonzalez, Christopher Cardona, Korey Stevanovic, John Faulkner, Amara Yunus, Alexandra Portugues, Amy Henriksen, et al.

    Time-of-day effects have been noted in a wide variety of cognitive behavioral tests, and perturbation of the circadian system, either at the level of the master clock in the SCN or downstream, impairs hippocampus-dependent learning and memory. A number of kinases, including the serine-threonine casein kinase 1 (CK1) isoforms CK1δ/ε, regulate the timing of the circadian period through post-translational modification of clock proteins. Modulation of these circadian kinases presents a novel treatment direction for cognitive deficits through circadian modulation. Here, we tested the potential for PF-670462, a small molecule inhibitor of CK1δ/ε, to improve cognitive performance in C57BL/6J mice in an array of behavioral tests. Compared to vehicle-treated mice tested at the same time of the circadian day, mice treated with PF-670462 displayed better recall of contextual fear conditioning, made fewer working memory errors in the radial arm water maze, and trained more efficiently in the Morris Water Maze. These benefits were accompanied by increased expression of activity-regulated cytoskeleton-associated protein (Arc) in the amygdala in response to an acute learning paradigm. Our results suggest the potential utility of CK1δ/ε inhibition in improving time-of-day cognitive performance.